05Jun/13

We'll go for differential pricing in India: Cadila's Patel – Livemint


Livemint

We’ll go for differential pricing in India: Cadila’s Patel
Livemint
Mumbai: Cadila Healthcare Ltd, which has been working on several new drugs under its dedicated discovery arm, announced its first discovery molecule saroglitazar, a first-of-its-kind medicine to treat dyslipidemia, a crucial condition not addressed in
Zydus’ new drug can control diabetes, cholesterolHindu Business Line
Zydus pioneers breakthrough with Lipaglyn to treat diabetic dyslipidemiapharmabiz.com
DCGI Approves Launch Of Zydus First NCE ‘Lipaglyn’RTT News

all 21 news articles »

05Jun/13

Biosimilars And Follow-On Biologics: World Market 2013-2023 – The Herald | HeraldOnline.com

Biosimilars And Follow-On Biologics: World Market 2013-2023
The Herald | HeraldOnline.com
Our study forecasts revenues of prominent biosimilar agents at molecular level: • Rituximab • Infliximab • Trastuzumab. There you discover how high sales can go, to 2023, with individual forecasts. You see what’s happening, understanding trends

and more »

05Jun/13

Second-hand tobacco smoke deadly too: Study – Times of India


Vancouver Sun

Second-hand tobacco smoke deadly too: Study
Times of India
Dr Rana Jugdeep Singh, Technical Advisor (Public Health), International Union Against Tuberculosis and Lung Disease (The Union) said on eve of World Environment Day, that “from one smoke-free jurisdiction, today India has achieved nearly 35 smoke-free
Anti-Smoking Media Campaigns Show Positive Results GloballyAllAfrica.com
Do National Smoking Bans Actually Work?TIME
Smoking bans must be enforcedThe National
Business Recorder
all 151 news articles »
05Jun/13

US Food and Drug Administration Approves REVLIMID® (lenalidomide) for the … – Fort Mills Times

US Food and Drug Administration Approves REVLIMID® (lenalidomide) for the
Fort Mills Times
approval was based on the results of MCL-001, a phase II, multi-center, single arm, open label study evaluating lenalidomide in 134 patients with MCL who had received prior treatment with rituximab, cyclophosphamide, an anthracycline (or

and more »

05Jun/13

Child With Weeks To Live Denied Lung Transplant Due To Controversial Organ … – ThinkProgress


ThinkProgress

Child With Weeks To Live Denied Lung Transplant Due To Controversial Organ
ThinkProgress
Child With Weeks To Live Denied Lung Transplant Due To Controversial Organ Donation Policy. By Aviva Shen on Jun 5, 2013 at 1:00 pm. (Credit: Save Sarah petition). Ten-year-old Philadelphia resident Sarah Murnaghan only has a couple weeks to live
Parents Fight Organ Donation Law to Save Daughter’s LifeChristian Post
Mother Pleads for Direct Organ Donation to Save DaughterPatch.com
Parents of dying 10-year-old girl challenge organ donor rule blocking her from Fox News
Delaware County Daily Times –Medical Daily –ABC News
all 206 news articles »